Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationLymphoma, Large B-Cell, DiffuseAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaLymphoma, B-CellMelphalanTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyTreatment OutcomeLymphoma, Non-HodgkinCyclophosphamideVincristineRemission InductionAmphotericin BSalvage TherapyDisease-Free SurvivalAntibodies, Monoclonal, Murine-DerivedStem CellsHodgkin DiseaseEtoposideLymphoma, FollicularDoxorubicinCytarabineRecurrenceSurvival RateMyeloablative AgonistsSurvival AnalysisPrognosisPrednisoneCarmustineHematopoietic Stem Cell MobilizationBone Marrow TransplantationRetrospective StudiesGraft vs Host DiseaseThiotepaBone Marrow PurgingHematologic NeoplasmsLymphoma, Mantle-CellLymphomaWhole-Body IrradiationAmyloidosisHematopoietic Stem CellsBoronic AcidsLymphoma, T-Cell, PeripheralDexamethasoneBusulfanPyrazinesFollow-Up StudiesAntifungal AgentsGraft SurvivalProto-Oncogene Proteins c-bcl-6Antineoplastic AgentsAntineoplastic Agents, AlkylatingAntigens, CD34AutograftsIfosfamideLiver TransplantationThalidomideInterferon-alphaTime FactorsInduction ChemotherapyMesenchymal Stem Cell TransplantationGranulocyte Colony-Stimulating FactorPodophyllotoxinGerminal CenterLeukapheresisFatal OutcomeNeoplasm, ResidualTransplantation ChimeraMaintenance ChemotherapyMycosesRecombinant ProteinsTissue DonorsCord Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteCell TransplantationNeoplasm StagingMitoxantroneNeoplasms, Second PrimaryKidney TransplantationEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsCisplatinMyelodysplastic SyndromesAntibodies, MonoclonalIdarubicinProspective StudiesLeukemia, Plasma CellInfusions, SpinalCarboplatinNeoplasm Recurrence, LocalChemotherapy, AdjuvantTranslocation, GeneticLymphoproliferative DisordersAdult Stem CellsBlood Component Removal